Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-19

Clinical Trial Update: Does Propranolol Attenuate Inflammatory Responses to a Psychological Stressor? [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether propranolol reduces inflammatory responses to a psychological stressor; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Stress, Psychological, Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2018-12-19